Pharmacokinetic Study of Single Doses of Clopidogrel, 75 mg and 300 mg, in Healthy Subjects
Status:
Completed
Trial end date:
2009-05-01
Target enrollment:
Participant gender:
Summary
The objectives of the study are to:
- Assess the within-subject variability of the pharmacokinetic profiles of the clopidogrel
and its active metabolite after a replicated single administration of 75 mg of
clopidogrel in healthy male and female subjects
- Assess the pharmacokinetic profiles of the clopidogrel and its active metabolite after
single administration of 75 or 300 mg of clopidogrel